ADO 5.26% 2.0¢ anteotech ltd

New research report 20th November 2015, page-3

  1. 24 Posts.
    lightbulb Created with Sketch. 4
    Great read and general update since their last report. I really like this part;

    Anteo is exploring strategic partnership opportunities to co-develop novel serum depletion products that have the potential to pre-treat hundreds of millions of patient specimens worldwide and improve the quality of reported patient results. A major collaboration with a highly reputed clinical partner will be announced soon.
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.